cas 1821770-96-0|| where to buy (S)-2-Cyclopropyl-1,2,3,4-tetrahydroquinoxaline

Nom du produit:(S)-2-Cyclopropyl-1,2,3,4-tetrahydroquinoxaline

IUPAC Name:(2S)-2-cyclopropyl-1,2,3,4-tetrahydroquinoxaline

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM221326-1g	1-2 Weeks	Ƽȷɐ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1821770-96-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1821770-96-0; Formule moléculaire:C11H14N2; Point de fusion:-; Code SMILES:[C@@H]1(C2CC2)NC3=C(C=CC=C3)NC1; Densité:

: Numéro de catalogue:CM221326; Poids moléculaire:174.25; Point d'ébullition:; N° Mdl:MFCD28133929; Stockage:

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.